Efaroxan
![]() | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
89197-32-0 |
| PubChem (CID) | 72016 |
| ChemSpider |
65015 |
| UNII |
G00490L21H |
| ChEMBL |
CHEMBL57895 |
| Chemical and physical data | |
| Formula | C13H16N2O |
| Molar mass | 216.28 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Efaroxan is an α2-adrenergic receptor antagonist[1] and antagonist of the imidazoline receptor.
See also
References
- ↑ Chopin P, Colpaert FC, Marien M (February 1999). "Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway". J. Pharmacol. Exp. Ther. 288 (2): 798–804. PMID 9918591.
This article is issued from Wikipedia - version of the 5/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
